Shashank Bhargava (S Bhargava)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 13

Top Venues

Dermatologic therapy

Clinical and experimental dermatology

Journal of cosmetic dermatology

Ruxmaniben Deepchand Gardi Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ruxmaniben Deepchand Gardi Medical College Jul 01 2019

India

Assistant Professor :: Dermatology

Publications

Sebastian Zimmer, Mohamad Goldust, Shashank Bhargava, Joanna Wegner, Stephan Grabbe, Petra Staubach-Renz
Combination therapy of recalcitrant severe psoriasis with psoriatic arthritis, diabetes nephropathy, and liver cirrhosis. Journal of cosmetic dermatology (2021)
Mehak Singh, Manoj K Pawar, Shashank Bhargava, Prakhar Gupta, Pankaj Adhicari
A novel association of efavirenz induced severe cutaneous adverse reactions with HLA- DRB1*03:01: A case-control study from North-East India. Dermatologic therapy 34 (2) (2021)
Mohamed Goldust, Uwe Wollina, Shashank Bhargava, Mrinal Gupta, Torello M Lotti
Trichostasis spinulosa misdiagnosed as alopecia areata. Dermatologic therapy 33 (4) (2020)
Shashank Bhargava, Rashmi Sarkar, George Kroumpouzos
Mental distress in dermatologists during COVID-19 pandemic: Assessment and risk factors in a global, cross-sectional study. Dermatologic therapy 33 (6) (2020)
Shashank Bhargava, Richa Rokde, Dipali Rathod, George Kroumpouzos
Employing dermatologists on the frontline against COVID-19: All hands on deck. Dermatologic therapy 33 (5) (2020)
Banu Farabi, Shashank Bhargava, Mohamed Goldust, Mehmet Fatih Atak
Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment". Dermatologic therapy 33 (6) (2020)
Rashmi Sarkar, Shashank Bhargava, Ram Chander, Dipali Rathod, Ajay Kumar Singh
Webinars as a mode of e-discussion by Indian dermatologists during the COVID-19 era: A boon or a bane? Dermatologic therapy 33 (6) (2020)
Mehak Singh, Shashank Bhargava, Manoj K Pawar, Gurpoonam Jatana, Anshu Maheswari, Atul Bothra
Jogger's facial dermatoses: An emerging entity in COVID-19 pandemic. Dermatologic therapy 33 (6) (2020)
Shashank Bhargava, Mrinal Gupta, George Kroumpouzos
Protection comes at a cost: Doctor's life inside personal protection equipment. Dermatologic therapy 33 (4) (2020)
H Gupta, M Gupta, Shashank Bhargava
Potential use of turmeric in COVID-19. Clinical and experimental dermatology 45 (7) (2020)
Mrinal Gupta, Aseem Sharma, Shashank Bhargava, Ayman Abdelmaksoud, Mohamed Goldust
Uncommon presentation of alopecia areata, severe psoriasis, and poliosis: A case report. Dermatologic therapy 33 (6) (2020)
Mrinal Gupta, Shashank Bhargava
Home remedies in different pediatric dermatoses: An observational study. Dermatologic therapy 33 (6) (2020)
Shashank Bhargava, Banu Farabi, D Rathod, A K Singh
The fate of major dermatology conferences and meetings of 2020: are e-conferences and digital learning the future? Clinical and experimental dermatology 45 (6) (2020)

Shashank Bhargava.css-eqlu8i{font-size:small;padding-left:4px;} (S Bhargava)

Publication Activity (10 Years)

Top Topics

Top Venues

Shashank Bhargava (S Bhargava)